Actualités Mylan NV - MYL | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Current Report Filing (8-k)

false000162361300016236132020-04-152020-04-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...

Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V.

Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, April 15, 2020...

Mylan Updates Its Efforts Regarding COVID-19

Mylan Updates Its Efforts Regarding COVID-19 PR Newswire HERTFORDSHIRE, England and PITTSBURGH, April 8, 2020...

Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept

Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept PR Newswire HERTFORDSHIRE...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed...

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

- Due to global impact of COVID-19 pandemic, transaction now expected to close in the second half of 2020 and Mylan’s EGM moved to June 30...

Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusiv...

Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Mylan NV (MYL)

Outils de qualité professionnelle, pour des investisseurs individuels.

MYL Actualités

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V.

Mylan Updates Its Efforts Regarding COVID-19

Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusiv...

Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Mylan Wins District Court Decision Against Sanofi's Lantus® SoloSTAR® Patent

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review

Statement of Changes in Beneficial Ownership (4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Mylan NV (MYL) Actualités

Mylan NV (MYL)

Outils de qualité professionnelle, pour des investisseurs individuels.

MYL Actualités

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V.

Mylan Updates Its Efforts Regarding COVID-19

Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusiv...

Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Mylan Wins District Court Decision Against Sanofi's Lantus® SoloSTAR® Patent

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Bevacizumab for Review

Statement of Changes in Beneficial Ownership (4)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités